SCHEMBL3584871

SCHEMBL3584871

CCOC(=O)C1C(=O)c2cc(C)ccc2C1c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP2D6 P10635 1/20 0.46
TSHR P16473 2/20 0.44
TP53 P04637 1/20 0.43
ALDH1A1 P00352 8/20 0.42
HTT P42858 3/20 0.42
MAPT P10636 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GAA P10253 1/20 0.41
KDM4E B2RXH2 2/20 0.41
GLA P06280 1/20 0.41
CYP2C9 P11712 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.39
CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8620891 0.79 MAPT (0.45) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL8784513 0.78 GAA (0.55) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL28478153 0.78 TSHR (0.48) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL490701 0.76 MEN1 (0.44) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL490807 0.75 MEN1 (0.46) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL8624326 0.71 MEN1 (0.39) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL8835165 0.70 TSHR (0.47) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL28902155 0.69 TSHR (0.52) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL8785010 0.69 MEN1 (0.46) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL15768562 0.68 HDAC4 (0.61) MEN1KMT2ACYP1A2CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741323-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-22 US disclosed
US-20070185109-A1 Idene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2007-08-09 US disclosed
EP-1740531-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-01-10 EP disclosed
WO-2005100303-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185109-A1 Idene derivatives and process for the preparation thereof INSR, PPARD, GPR119 MEN1 2055/4885KMT2A 3388/4885CYP1A2 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.